Kalaris Therapeutics Inc

KLRS

KLRSKalaris Therapeutics Inc US flag

NASDAQ Global Market

3.97

USD

-0.07

- -

74.25MMarket Cap

Income Statement (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -
- Operating Expenses	14	13	52	46
+ Selling, General & Admin	2	2	7	15
+ Research & Development	12	12	45	31
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	-14	-13	-52	-46
- Non-Operating (Income) Loss	1	1	17	-3
+ Interest Expense, Net	- -	1	3	1
+ Interest Expense	- -	1	3	1
- Interest Income	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	1	1	15	-4
Pretax Income	-15	-15	-69	-43
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	-15	-15	-69	-43
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	-15	-15	-69	-43
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	-15	-15	-69	-43
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-15	-15	-69	-43
EBIT	-14	-13	-52	-46
EBITDA	-14	-13	-52	-46
EBITDA Margin (%)	- -	- -	- -	- -
EBITA	-14	-13	-52	-46
Gross Margin (%)	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -
Basic Weighted Avg Shares	1	1	19	15
Basic EPS, GAAP	-11.64	-11.05	-3.7	-2.85
Basic EPS from Cont Ops	-11.64	-11.05	-3.7	-2.85
Diluted Weighted Avg Shares	1	1	19	15
Diluted EPS, GAAP	-11.64	-11.05	-3.7	-2.85
Diluted EPS from Cont Ops	-11.64	-11.05	-3.7	-2.85

Balance Sheet (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Current Assets	4	3	3	119
+ Cash, Cash Equivalents & STI	3	3	2	118
+ Cash & Cash Equivalents	3	3	2	98
+ ST Investments	- -	- -	- -	20
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	1	- -	1	1
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	4	3
+ Property, Plant & Equip, Net	- -	- -	- -	1
+ Property, Plant & Equip	- -	- -	- -	1
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	- -	- -	4	1
+ Total Intangible Assets	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	4	1
Total Assets	4	3	6	122
+ Payables & Accruals	5	3	3	8
+ Accounts Payable	3	2	2	1
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	3	1	2	7
+ ST Debt	- -	- -	20	- -
+ ST Borrowings	- -	- -	20	- -
+ ST Finance Leases	- -	- -	- -	- -
+ Other ST Liabilities	- -	1	2	2
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	- -	1	2	2
Total Current Liabilities	6	4	25	10
+ LT Debt	3	- -	- -	1
+ LT Borrowings	3	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	1
+ Other LT Liabilities	25	44	78	32
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	25	44	78	32
Total Noncurrent Liabilities	28	44	78	33
Total Liabilities	34	48	103	43
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	2	2	20	239
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	2	2	20	239
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-33	-47	-117	-160
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-30	-45	-97	79
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-30	-45	-97	79
Total Liabilities & Equity	4	3	6	122
Shares Outstanding	19	19	19	23
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	1
Net Debt	- -	-3	18	-98
Net Debt to Equity	-0.64	7.04	-18.53	-124.41
Tangible Common Equity Ratio	-776.4	-1,350.65	-1,567.93	64.74
Current Ratio	0.69	0.85	0.11	12.23
Cash Conversion Cycle	- -	- -	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

+ Net Income	-15	-15	-69	-43
+ Depreciation & Amortization	- -	- -	- -	- -
+ Non-Cash Items	2	2	51	2
+ Stock-Based Compensation	- -	- -	1	2
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -
+ Other Non-Cash Adj	2	2	50	- -
+ Chg in Non-Cash Work Cap	3	-1	-2	3
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	-1	1	-1	2
+ Inc (Dec) in Accts Payable	4	-2	-1	2
+ Inc (Dec) in Other	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	-10	-14	-21	-38
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	- -	42
+ Increase in Capital Stock	- -	- -	- -	42
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	-20
+ Dec in LT Investment	- -	- -	- -	15
+ Inc in LT Investment	- -	- -	- -	-35
+ Net Cash From Acq & Div	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	-20
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	4	6	20	8
+ Cash From Debt	4	6	20	8
+ Repayments of Debt	- -	- -	- -	- -
+ Other Financing Activities	8	8	-1	106
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	13	14	19	155
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	3	- -	-2	97
EBITDA	-14	-13	-52	-46
EBITDA Margin (%)	- -	- -	- -	- -
Free Cash Flow	-10	-14	-21	-39
Net Cash Paid for Acquisitions	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-8	-1	-31
Free Cash Flow per Basic Share	-7.35	-10.62	-1.11	-2.53
Price/Free Cash Flow	-369.16	-33.85	-201.03	-3.38
Cash Flow to Net Income	0.63	0.96	0.3	0.88
Capital Expenditures	- -	- -	- -	- -